Louise S. Kristensen

Odense, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Acquired amegakaryocytic thrombocytopaenia after treatment with immune checkpoint inhibitor as part of neoadjuvant treatment in a patient with bilateral breast cancer.

Acquired amegakaryocytic thrombocytopaenia after treatment with immune checkpoint inhibitor as part of neoadjuvant treatment in a patient with bilateral breast cancer.

Journal: BMJ case reports
Published: March 19, 2025

Disseminated Marginal Zone Lymphoma in a Patient with Lyme Neuroborreliosis: A Case Report.

Disseminated Marginal Zone Lymphoma in a Patient with Lyme Neuroborreliosis: A Case Report.

Journal: Case reports in oncology
Published: July 10, 2024

Methylation microarray-based detection of clinical copy-number aberrations in CLL benchmarked to standard FISH analysis.

Methylation microarray-based detection of clinical copy-number aberrations in CLL benchmarked to standard FISH analysis.

Journal: Genomics
Published: May 16, 2022

Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center.

Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center.

Journal: Journal of clinical medicine
Published: March 01, 2022

Effect of paternal health on pregnancy loss-A review of current evidence.

Effect of paternal health on pregnancy loss-A review of current evidence.

Journal: Andrologia
Published: January 22, 2021

IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.

IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.

Journal: Haematologica
Published: September 10, 2020

Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment.

Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment.

Journal: Epigenomics
Published: September 06, 2018

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.

Journal: European journal of haematology
Published: November 03, 2015

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia.

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia.

Journal: Leukemia research
Published: September 12, 2014

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

Journal: Blood
Published: August 29, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026